TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group

Overview of attention for article published in BMC Cancer, June 2017

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 274 followers.

医学雑誌も英国か米国かで違うよな>RT Lancetは英語でJCOは米語だし。イタリア人が書いた同じTRIBE試験でも雰囲気違う Lancet Oncol. https://t.co/WVTsVfBCd4 J Clin Oncol. https://t.co/q1wmaGGAjq BMC Cancer https://t.co/3BL0cd3sRn Ann Oncol https://t.co/IC2o65khgH

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.